AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32988369 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (group M)
Number of subjects: 0
Study 33387346 — intervention group
Group type: EXPERIMENTAL
Intervention: White Mineral Trioxide Aggregate (WMTA)
Number of subjects: 60
Study 33387346 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine™ (BD)
Number of subjects: 60
Study 33387346 — intervention group
Group type: COMPARATOR
Intervention: Control group (positive controls with no treatment)
Number of subjects: 60
Study 33387346 — intervention group
Group type: COMPARATOR
Intervention: Control group (negative controls with normal saline)
Number of subjects: 60
Study 33387346 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 33154058 — intervention group
Group type: EXPERIMENTAL
Intervention: Education only
Number of subjects: 123
Study 33154058 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening approach
Number of subjects: 123
Study 33154058 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor control-focused approach
Number of subjects: 123
Study 33154058 — intervention group
Group type: COMPARATOR
Intervention: All intervention groups
Number of subjects: 123
Study 36147397 — intervention group
Group type: EXPERIMENTAL
Intervention: Single visit root canal therapy
Number of subjects: 60
Study 36147397 — intervention group
Group type: COMPARATOR
Intervention: Multiple visit root canal therapy
Number of subjects: 60
Study 35379296 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential multiple ascending doses of solnatide
Number of subjects: 16
Study 34155991 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified combined program of physical therapy and ergotherapy (including PNF, balance training, upright posture correction, constraint‐induced movement therapy, dual task activities, stimulation of the affected side in daily activities, targeted therapy) for 3 months
Number of subjects: 58
Study 34155991 — intervention group
Group type: COMPARATOR
Intervention: Proprioceptive neuromuscular facilitation (PNF), balance training, ergotherapeutic intervention, and exercises improving fine motor skills
Number of subjects: 58
Study 35876893 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-speed PRF + OFD
Number of subjects: 22
Study 35876893 — intervention group
Group type: COMPARATOR
Intervention: OFD
Number of subjects: 22
Study 33845853 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable activity tracker (Fitbit Flex) combined with digital behaviour change resources and weekly challenges delivered via Facebook
Number of subjects: 275
Study 33845853 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported physical activity
Number of subjects: 275
Study 33845853 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 275
Study 32381562 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 200 mg every 2 weeks (Q2W) full maintenance dose
Number of subjects: 736
Study 32381562 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 200 mg every 4 weeks (Q4W) reduced maintenance dose
Number of subjects: 736
Study 32381562 — intervention group
Group type: COMPARATOR
Intervention: Placebo (withdrawal)
Number of subjects: 736
Study 36070710 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 1323
Study 36070710 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 1323
Study 36070710 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 1323
Study 34852764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascia iliaca compartment block using the supra-inguinal approach (group F)
Number of subjects: 38
Study 34852764 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided fascia iliaca compartment block using the classical approach (group C)
Number of subjects: 38
Study 34852764 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 33269511 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes (TRS‐HFDM)
Number of subjects: 5123
Study 32052925 — intervention group
Group type: EXPERIMENTAL
Intervention: Test warfarin sodium tablet
Number of subjects: 56
Study 32052925 — intervention group
Group type: COMPARATOR
Intervention: Reference product Coumadin (2.5 mg)
Number of subjects: 56
Study 35108378 — intervention group
Group type: EXPERIMENTAL
Intervention: High Carbohydrate groups (HC-Starch and HC-Sugar)
Number of subjects: 64
Study 33792551 — intervention group
Group type: EXPERIMENTAL
Intervention: Text Messaging Intervention (TMI) for 6 weeks
Number of subjects: 77
Study 33792551 — intervention group
Group type: COMPARATOR
Intervention: Group-based cessation counseling and nicotine patches
Number of subjects: 77
Study 33730752 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.25 mg/kg
Number of subjects: 45
Study 33730752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 32939044 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34048554 — intervention group
Group type: EXPERIMENTAL
Intervention: Delays of ≥3 days to concordant antibiotic treatment
Number of subjects: 1203
Study 34048554 — intervention group
Group type: COMPARATOR
Intervention: Delays of 1-2 days to concordant antibiotic treatment
Number of subjects: 1203
Study 34048554 — intervention group
Group type: EXPERIMENTAL
Intervention: Delays in appropriate antibiotic treatment
Number of subjects: 1203
Study 33494103 — intervention group
Group type: EXPERIMENTAL
Intervention: Osstell device
Number of subjects: 80
Study 34775223 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate goal‐dose enteral nutrition (IGEN)
Number of subjects: 406
Study 34775223 — intervention group
Group type: COMPARATOR
Intervention: Gradual goal‐dose enteral nutrition (GGEN)
Number of subjects: 406
Study 32080084 — intervention group
Group type: EXPERIMENTAL
Intervention: Ucha‐Shinki‐Hwan (UCHA)
Number of subjects: 164
Study 32080084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 36817812 — intervention group
Group type: EXPERIMENTAL
Intervention: Dracocephalum extract (250 mg, twice daily for one month)
Number of subjects: 110
Study 36817812 — intervention group
Group type: COMPARATOR
Intervention: Placebo (250 mg starch, twice daily for one month)
Number of subjects: 110
Study 36817812 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Dracocephalum and placebo
Number of subjects: 110
Study 33067692 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 Hz electrical stimulation
Number of subjects: 90
Study 33067692 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1 Hz electrical stimulation
Number of subjects: 90
Study 33067692 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 Hz electrical stimulation
Number of subjects: 90
Study 33067692 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation at bladder dome
Number of subjects: 90
Study 33067692 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation at trigone
Number of subjects: 90
Study 33067692 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation at proximal urethra (men only)
Number of subjects: 90
Study 33067692 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation at distal urethra
Number of subjects: 90
Study 36890047 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchman 2.5 device
Number of subjects: 2258
Study 32721239 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaved cartilage plus platelet-rich fibrin (SC+PRF)
Number of subjects: 200
Study 32721239 — intervention group
Group type: COMPARATOR
Intervention: Diced cartilage (DC)
Number of subjects: 200
Study 35276337 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-out referral approach
Number of subjects: 0
Study 35276337 — intervention group
Group type: COMPARATOR
Intervention: Opt-in referral approach
Number of subjects: 0
Study 34547006 — intervention group
Group type: EXPERIMENTAL
Intervention: Black rice extract (1 g/d)
Number of subjects: 105
Study 34547006 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin, 1 g/d)
Number of subjects: 105
Study 35536441 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlormethine gel
Number of subjects: 0
Study 35536441 — intervention group
Group type: COMPARATOR
Intervention: Chlormethine ointment
Number of subjects: 0
Study 33213488 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial nerve electrostimulation (TNES)
Number of subjects: 44
Study 33213488 — intervention group
Group type: COMPARATOR
Intervention: Parasacral electrostimulation (PSES)
Number of subjects: 44
Study 34862191 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile stimulation during PPV
Number of subjects: 40
Study 34862191 — intervention group
Group type: COMPARATOR
Intervention: No tactile stimulation (immediately prior to stimulation)
Number of subjects: 40
Study 35752028 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model based on liquid biopsy for NSCLC
Number of subjects: 500
Study 35752028 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram parameters including gene mutation type, differentiation degree, CTC content, and brain metastasis
Number of subjects: 500
Study 33723806 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg
Number of subjects: 17
Study 33723806 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant 25 mg
Number of subjects: 17
Study 32149456 — intervention group
Group type: EXPERIMENTAL
Intervention: Similar Age Same Gender (SASG)
Number of subjects: 485
Study 32149456 — intervention group
Group type: EXPERIMENTAL
Intervention: Similar Age Mixed Gender (SAMG)
Number of subjects: 485
Study 32149456 — intervention group
Group type: COMPARATOR
Intervention: Mixed Age Mixed Gender (MAMG)
Number of subjects: 485
Study 34973100 — intervention group
Group type: EXPERIMENTAL
Intervention: Critically reflective dialogue
Number of subjects: 75
Study 34973100 — intervention group
Group type: COMPARATOR
Intervention: Social Determinants of Health (SDoH) discussion
Number of subjects: 75
Study 33427160 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (INFANT program)
Number of subjects: 492
Study 32887793 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA + AA supplementation (200 mg DHA + 200 mg AA daily for 180 days)
Number of subjects: 377
Study 32887793 — intervention group
Group type: COMPARATOR
Intervention: Placebo (400 mg corn oil)
Number of subjects: 377
Study 35753841 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderna COVID-19 Vaccine (mRNA-1273)
Number of subjects: 30000
Study 35753841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30000
Study 33457089 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 1420
Study 36351740 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-orifice catheters
Number of subjects: 182
Study 36351740 — intervention group
Group type: COMPARATOR
Intervention: Multiorifice catheters
Number of subjects: 182
Study 33883880 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid intravenous injection of omeprazole (group A)
Number of subjects: 120
Study 33883880 — intervention group
Group type: COMPARATOR
Intervention: Continuous micropump infusion of omeprazole (group B)
Number of subjects: 120
Study 33883880 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 120
Study 35105621 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT)
Number of subjects: 318
Study 35105621 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 318
Study 33888532 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training (spinning) three times per week for 12 weeks
Number of subjects: 40
Study 33888532 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study 33171172 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletonized LIMA
Number of subjects: 62
Study 33171172 — intervention group
Group type: COMPARATOR
Intervention: Pedicled LIMA
Number of subjects: 62
Study 33188069 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic signals in the anterior prefrontal cortex (aPFC) during forced-choice trials
Number of subjects: 0
Study 33188069 — intervention group
Group type: EXPERIMENTAL
Intervention: Interregional negative coupling between the prefrontal region and the ventral striatum (VS)
Number of subjects: 0
Study 33188069 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced ventral striatal activity during consumption of liquid rewards
Number of subjects: 0
Study 35945859 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium gluconate
Number of subjects: 60
Study 35945859 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline
Number of subjects: 60
Study 33607806 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway-supreme (LM-S)
Number of subjects: 100
Study 33607806 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 100
Study 32623487 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate 5 mg IV
Number of subjects: 141
Study 32623487 — intervention group
Group type: COMPARATOR
Intervention: No further active treatment
Number of subjects: 141
Study 35255866 — intervention group
Group type: EXPERIMENTAL
Intervention: SPRAT programme
Number of subjects: 1986
Study 35255866 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual school programme)
Number of subjects: 1986
Study 35010536 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping with squat exercise (KTSE)
Number of subjects: 40
Study 35010536 — intervention group
Group type: COMPARATOR
Intervention: Sham taping with squat exercise (SKTSE)
Number of subjects: 40
Study 36036760 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose anticoagulation
Number of subjects: 390
Study 36036760 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 390
Study 36036760 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose prophylactic anticoagulation
Number of subjects: 390
Study 36036760 — intervention group
Group type: COMPARATOR
Intervention: No antiplatelet therapy
Number of subjects: 390
Study 33599794 — intervention group
Group type: EXPERIMENTAL
Intervention: DARA SC
Number of subjects: 67
Study 33599794 — intervention group
Group type: COMPARATOR
Intervention: DARA IV
Number of subjects: 67
Study 34816812 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly cushioned running shoe (HCS)
Number of subjects: 32
Study 34816812 — intervention group
Group type: COMPARATOR
Intervention: Control running shoe (CON)
Number of subjects: 32
Study 32141136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary AM/AP ratio of 0.23-0.35
Number of subjects: 960
Study 32141136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary amylase at 6,000 U/kg
Number of subjects: 960
Study 32141136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary AM/AP ratio increase
Number of subjects: 960
Study 32141136 — intervention group
Group type: EXPERIMENTAL
Intervention: High AM/AP diet
Number of subjects: 960
Study 32141136 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylase supplementation
Number of subjects: 960
Study 32141136 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (6,000 U/kg) of amylase
Number of subjects: 960
Study 32141136 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous amylase
Number of subjects: 960
Study 33486048 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-supervised aerobic exercise (20-minute low-impact aerobic exercise video, at least three times per week for three months)
Number of subjects: 140
Study 33486048 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-supervised aerobic exercise
Number of subjects: 140
Study 33486048 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care only
Number of subjects: 140
Study 35653155 — intervention group
Group type: EXPERIMENTAL
Intervention: GWL packs
Number of subjects: 357
Study 35653155 — intervention group
Group type: COMPARATOR
Intervention: Blank packs
Number of subjects: 357
Study 35653155 — intervention group
Group type: COMPARATOR
Intervention: US packs
Number of subjects: 357
Study 33002971 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition with protein supplementation
Number of subjects: 0
Study 33002971 — intervention group
Group type: EXPERIMENTAL
Intervention: Early supplemental parenteral nutrition
Number of subjects: 0
Study 33002971 — intervention group
Group type: EXPERIMENTAL
Intervention: Early total parenteral nutrition
Number of subjects: 0
Study 33002971 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding
Number of subjects: 0
Study 33002971 — intervention group
Group type: COMPARATOR
Intervention: High-dose vasopressors
Number of subjects: 0
Study 35186243 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic radical surgery combined with neoadjuvant chemotherapy
Number of subjects: 100
Study 35186243 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic radical surgery
Number of subjects: 100
Study 37267171 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) and general health education
Number of subjects: 101
Study 37267171 — intervention group
Group type: COMPARATOR
Intervention: Control group (general health education only)
Number of subjects: 101
Study 33590330 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (some improvement)
Number of subjects: 170
Study 33590330 — intervention group
Group type: COMPARATOR
Intervention: Control group (no improvement)
Number of subjects: 170
Study 32448110 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 63
Study 34266319 — intervention group
Group type: EXPERIMENTAL
Intervention: MIC-1 levels for detecting precancerous lesions
Number of subjects: 2759
Study 34266319 — intervention group
Group type: EXPERIMENTAL
Intervention: MIC-1 levels for detecting colorectal cancer (CRC)
Number of subjects: 2759
Study 34266319 — intervention group
Group type: COMPARATOR
Intervention: MIC-1 levels vs. CEA, CA19-9, CA24-2 for precancerous lesions
Number of subjects: 2759
Study 34266319 — intervention group
Group type: COMPARATOR
Intervention: MIC-1 levels vs. CEA, CA19-9, CA24-2 for CRC
Number of subjects: 2759
Study 34266319 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of MIC-1, CEA, CA19-9, CA24-2 for CRC diagnosis
Number of subjects: 2759
Study 32242808 — intervention group
Group type: EXPERIMENTAL
Intervention: Musculoskeletal ultrasound (MUS) data shared with the primary rheumatologist
Number of subjects: 94
Study 32242808 — intervention group
Group type: COMPARATOR
Intervention: Control group (MUS data not shared)
Number of subjects: 94
Study 34039693 — intervention group
Group type: EXPERIMENTAL
Intervention: RAMP-group education (HBPM group education)
Number of subjects: 287
Study 34039693 — intervention group
Group type: COMPARATOR
Intervention: RAMP-individual counselling (Control)
Number of subjects: 287
Study 34817581 — intervention group
Group type: EXPERIMENTAL
Intervention: PRISM intervention
Number of subjects: 57
Study 35168030 — intervention group
Group type: EXPERIMENTAL
Intervention: Equisetum arvense L. (EA) 900 mg/day
Number of subjects: 58
Study 35168030 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 25 mg/day
Number of subjects: 58
Study 34078323 — intervention group
Group type: COMPARATOR
Intervention: Standard tacrolimus-based immunosuppressive regimen with mycophenolate mofetil and glucocorticoids
Number of subjects: 374
Study 34078323 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced CNI exposure in combination with everolimus and glucocorticoids
Number of subjects: 374
Study 32249256 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI) using J-Valve
Number of subjects: 18
Study 32728879 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 cup of espresso coffee/day
Number of subjects: 21
Study 32728879 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 cups of espresso coffee/day
Number of subjects: 21
Study 32728879 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 cup of espresso coffee plus 2 cocoa-based products containing coffee, twice per day
Number of subjects: 21
Study 32068014 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper-oxide-impregnated linens
Number of subjects: 1282
Study 32068014 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper-oxide-treated hard surfaces
Number of subjects: 1282
Study 32068014 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital linens
Number of subjects: 1282
Study 32068014 — intervention group
Group type: COMPARATOR
Intervention: Control for central-line-associated bloodstream infections and catheter-associated urinary tract infections
Number of subjects: 1282
Study 36347767 — intervention group
Group type: EXPERIMENTAL
Intervention: EVAHEART®2 left ventricular assist device (EVA2)
Number of subjects: 25
Study 36347767 — intervention group
Group type: COMPARATOR
Intervention: HeartMate 3 LVAS (HM3)
Number of subjects: 25
Study 33857946 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 60
Study 33857946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32718144 — intervention group
Group type: EXPERIMENTAL
Intervention: High SIRI group (≥ 0.89)
Number of subjects: 124
Study 32718144 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on SIRI, body mass index, weight loss, carbohydrate antigen 19-9, radical surgery, and TNM stage
Number of subjects: 124
Study 32718144 — intervention group
Group type: COMPARATOR
Intervention: Low SIRI group (< 0.89)
Number of subjects: 124
Study 33245709 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation
Number of subjects: 50
Study 33245709 — intervention group
Group type: COMPARATOR
Intervention: Liquid paraffin (placebo) inhalation
Number of subjects: 50
Study 33245709 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac intake
Number of subjects: 50
Study 33417065 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct trocar access (n = 68)
Number of subjects: 135
Study 33417065 — intervention group
Group type: COMPARATOR
Intervention: Veress needle access (n = 67)
Number of subjects: 135
Study 35019896 — intervention group
Group type: EXPERIMENTAL
Intervention: Job crafting intervention program
Number of subjects: 281
Study 35019896 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 281
Study 34684438 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month lifestyle intervention program
Number of subjects: 259
Study 32205528 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo intervention during green screens
Number of subjects: 372